In an effort to combat the chemotherapy and radiation therapy resistance of glioblastoma (GB) cells, Yathindranath et al. prepared LNPs loaded with siRNA targeting the resistance gene Spermidine/spermine N1-acetyltransferase 1 (SAT1) [45]. This evidence concerns the gene SAT1 and glioblastoma.